There have been no previous studies comparing patients with SLE with HCs using the homodimer of S100A8; however, a study of 37 patients with SLE showed a significant decrease in serum S100A8 levels after treatment (35). This evidence concerns the gene S100A8 and systemic lupus erythematosus.